Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.
about
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primatesVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerYellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytesDisassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirusInhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replicationUnderstanding and altering cell tropism of vesicular stomatitis virusInfluence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice.Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.Viral induction of central nervous system innate immune responses.Role of interleukin-12 in primary influenza virus infectionPseudorabies virus-induced leukocyte trafficking into the rat central nervous systemSafety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primatesDistinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNSRIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes.Interplay between innate immunity and negative-strand RNA viruses: towards a rational modelInterferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis.Activation of microglia by borna disease virus infection: in vitro studyAntiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidateNeurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesViral-induced encephalitis initiates distinct and functional CD103+ CD11b+ brain dendritic cell populations within the olfactory bulb.Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.The antiviral drug ganciclovir does not inhibit microglial proliferation and activationBreaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infectionOncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system.Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus.Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challengeVirus Infections on Prion Diseased Mice Exacerbate Inflammatory Microglial Response.Sleep and behavior during vesicular stomatitis virus induced encephalitis in BALB/cJ and C57BL/6J miceViral CNS infections: role of glial pattern recognition receptors in neuroinflammationThe Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitorsAmalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spreadVesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice.
P2860
Q21090120-46402FAE-17D2-4C93-B123-9D99B308FE24Q27021839-01C7162B-A458-4A1A-8020-C177E31348ECQ27469887-FBD89DEC-EC62-4FEA-905E-C7B0416E169EQ27480796-FFE1A586-03B2-4B79-817C-BD1CC36A0A45Q27480830-0D8F0C1F-4E63-4118-8792-C15F0B3F6D8CQ27687067-FDE827AB-E865-4D84-BDE4-58B923C6CD10Q30497868-889F5A49-C167-4D3D-BC48-EF6D138596D5Q33579385-8AFF4B4C-A74C-4851-A78A-343FA75DB8AAQ33614368-A5F804C1-37CB-4587-A216-B32984E49C5BQ33707371-19CC3D33-E224-40CD-A6DC-0B6D31238B3FQ33784078-10C0B3F6-BE12-4EFC-9652-A49C7421A535Q33785423-37068193-43E0-4136-85DD-6734487D0178Q33832168-55833F4E-05C3-49F0-94C6-40C5938BD9E6Q34117786-3D5FC5DF-DFFA-4121-86B3-D3B6E64DD64AQ34158564-368DE907-774A-4FD7-8713-FDCB630198EBQ34212787-A0B15536-2CDD-4872-BB94-9E19A51E3E1FQ34277052-08C4A43E-3D26-4897-908F-0F2075188495Q35185949-9E50C634-6551-4CB9-9042-3C2F304142F8Q35212646-8FFE0535-E956-40FD-9177-29485451779BQ35635393-E45F2B7A-E028-4DAD-A8E2-2706673A6EDDQ35677531-4E4017A1-6AD9-45A8-B2CD-6085409310E2Q35781967-BC203834-D7F5-470F-B481-D7AFD70AD601Q35924747-D147CC21-C644-49D2-A974-6E6D253910ADQ36049446-373B1A46-DC9A-40A0-9C05-0DE6E2429D47Q36134639-01C03D55-B3D3-4262-8C96-AF1E4256F108Q36202610-B3E63508-722B-4E4C-8678-2B61A90D4F48Q37076666-9E30AD8D-F377-43BE-940F-AC44EA7E395FQ37123143-653B8ED7-1C30-4838-B2F0-009527DBAFE3Q37251088-E9B0C5AD-CA66-4A70-A3D3-7ED4C043103CQ37322441-DDAC29AC-52BE-4444-9F18-3A869179B7DAQ37373616-1EFB6AE8-5386-405C-A0E2-F1532768BAF9Q37418123-BA374D17-2BBB-472E-9FD1-DF65352039CBQ37451959-B412BC02-A375-4711-895D-30ECBAE3003BQ37492658-18834663-2A69-4CE3-862F-99D7CA47BC9DQ37648216-62DF95D7-BE2D-4F82-94F9-5B6A43AF1746Q38020836-20AD9A57-7C8F-4E07-9540-C36589AC0BC5Q38292935-AF9B8C60-8CCC-4CCB-BADC-A6D34B2A2E77Q39096636-6D13BFB6-F4B5-425D-B210-C84BFB3C9EC5Q39127778-4629C54F-0D10-49A1-9926-61B899492381Q39748967-0E0BD526-221C-4C8C-B68E-FB8205EABA94
P2860
Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Vesicular stomatitis virus inf ...... innate and acquired immunity.
@en
type
label
Vesicular stomatitis virus inf ...... innate and acquired immunity.
@en
prefLabel
Vesicular stomatitis virus inf ...... innate and acquired immunity.
@en
P2093
P2860
P1433
P1476
Vesicular stomatitis virus inf ...... innate and acquired immunity.
@en
P2093
P2860
P304
P407
P577
1995-10-01T00:00:00Z